2008
DOI: 10.1016/j.transproceed.2008.03.077
|View full text |Cite
|
Sign up to set email alerts
|

Cadaveric Renal Transplantation: The Chennai Experience

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
10
1

Year Published

2011
2011
2020
2020

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 19 publications
(12 citation statements)
references
References 3 publications
1
10
1
Order By: Relevance
“…[12] In our study, 48.5% had DGF, 21.8% had acute rejection, mean CIT was 5.66 h, 1 and 5 years patient survival 80.2% and 76.3% and graft survival 82.6% and 80%, respectively. When compared to other Indian studies,[131415] the incidence of DGF was higher in our study despite having shorter mean cold ischemic time [Table 5]. …”
Section: Discussioncontrasting
confidence: 64%
“…[12] In our study, 48.5% had DGF, 21.8% had acute rejection, mean CIT was 5.66 h, 1 and 5 years patient survival 80.2% and 76.3% and graft survival 82.6% and 80%, respectively. When compared to other Indian studies,[131415] the incidence of DGF was higher in our study despite having shorter mean cold ischemic time [Table 5]. …”
Section: Discussioncontrasting
confidence: 64%
“…18 In a study by Mani, 1-year and 4-year graft survivals of 88 DDRT in Chennai were 72% and 63%, respectively, and patient survival was hardly different from graft survival. 19 Five-year patient and graft survivals of 68 DDRT in Chennai were 61.7% and 58.8%, respectively, with biopsy-proven acute rejection in 26.4%, DGF in 50%, and CIT of 5.6 ± 3.2 h. 20 Centers report remarkable differences in the quality of kidney they harvest which may contribute to differences in long-term results. ICU care and skill of the donor maintenance and recovering team may be a contributing factor.…”
Section: Discussionmentioning
confidence: 99%
“…This has resulted in an acceptable rate of DGF (34%) in our cases. [5111221222324] DGF is an independent predictor of poor graft survival in cadaveric renal transplant recipients. [22]…”
Section: Discussionmentioning
confidence: 99%
“…The diagnosis of renal allograft rejection was suggested by a decline in renal function confirmed by ultrasound-guided percutaneous allograft biopsy as per the modified Banff classification. [1011] Cellular rejections were treated with methyl prednisone (MP) 500 mg × 3-5 doses ± r-ATG 1.5 mg/kg single dose. Humoral rejections were treated with plasmapheresis (50 ml/kg per session × 4-8 sessions) + intravenous immunoglobulins (IVIG) 0.4 g/kg × 5-10 doses ± rituximab 375 mg/m 2 Body surface area BSA single dose or bortezomib (1.3 mg/m 2 BSA × 4 dosages).…”
Section: Methodsmentioning
confidence: 99%